Medicinal cannabis for chronic pain: The bermuda triangle of low-quality studies, countless meta-analyses and conflicting recommendations
- PMID: 35363933
- PMCID: PMC9323487
- DOI: 10.1002/ejp.1946
Medicinal cannabis for chronic pain: The bermuda triangle of low-quality studies, countless meta-analyses and conflicting recommendations
Conflict of interest statement
Elon Eisenberg received consulting fees, speaking fees, and/or honoraria from Rafa Laboratories, Syqe medical, Medison, Teva, Pfizer. Bart Morlion is past president of the European Pain Federation EFIC and was member of the EFIC task force which published a position paper on cannabis‐based medicines and medical cannabis for pain management. Over the last 5 years he received fees for service for speaker's and/or consultancy activities from Grünenthal, Lilly, Mundipharma, Pfizer, Krka, Ache, Sandoz, Shionogi, TEVA, GSK, Kyowa‐Kirin, Boston Scientific, Reckitt & Benckiser. Silviu Brill is Honorary Secretary of European Pain Federation EFIC and was member of the EFIC task force, which published a position paper on cannabis‐based medicines and medical cannabis for pain management. He received reimbursement for travelling and accommodation by Bioevents, a congress organiser, for co‐organising a congress on controversies on cannabis‐based medicines in 2018 and 2019. He received consulting and speaking fees from Rafa Laboratories, Pfizer, TEVA and Dexcell. Winfried Häuser has received reimbursement for travelling and accommodation by Bioevents, a congress organiser, for co‐organising a congress on controversies on cannabis‐based medicines in 2018 and 2019. He was the head of an EFIC task force of a position paper on cannabis‐based medicines and medical cannabis for pain management and member of a task force of a position paper on the same topic by the German Pain Society.
Comment in
-
Conflicting recommendations: A labyrinth for the clinician and patients: A comment to Eisenberg's et al. "medical cannabis for chronic pain".Eur J Pain. 2023 Jan;27(1):176-177. doi: 10.1002/ejp.2050. Epub 2022 Nov 9. Eur J Pain. 2023. PMID: 36317603 No abstract available.
References
-
- Aviram, J. , Pud, D. , Gershoni, T. , Schiff‐Keren, B. , Ogintz, M. , Vulfsons, S. , Yashar, T. , Adahan, H. M. , Brill, S. , Amital, H. , Goor‐Aryeh, I. , Robinson, D. , Green, L. , Segal, R. , Fogelman, Y. , Tsvieli, O. , Yellin, B. , Vysotski, Y. , Morag, O. , … Eisenberg, E. (2021). Medical cannabis treatment for chronic pain: Outcomes and prediction of response. European Journal of Pain, 25(2), 359–374. 10.1002/ejp.1675. Epub 2020 Nov 9 PMID: 33065768. - DOI - PubMed
-
- Fisher, E. , Moore, R. A. , Fogarty, A. E. , Finn, D. P. , Finnerup, N. B. , Gilron, I. , Haroutounian, S. , Krane, E. , Rice, A. S. C. , Rowbotham, M. , Wallace, M. , & Eccleston, C. (2021). Cannabinoids, cannabis, and cannabis‐based medicine for pain management: A systematic review of randomised controlled trials. Pain, 162(Suppl 1), S45–S66. 10.1097/j.pain.0000000000001929. PMID: 32804836. - DOI - PubMed
-
- Häuser, W. , Finn, D. P. , Kalso, E. , Krcevski‐Skvarc, N. , Kress, H. G. , Morlion, B. , Perrot, S. , Schäfer, M. , Wells, C. , & Brill, S. (2018). European Pain Federation (EFIC) position paper on appropriate use of cannabis‐based medicines and medical cannabis for chronic pain management. European Journal of Pain, 22, 1547–1564. 10.1002/ejp.1297 - DOI - PubMed
-
- International Association for the Study of Pain . (2021). IASP Position Statement on the Use of Cannabinoids to Treat Pain. March 21, 2021. Retrieved from https://www.iasp‐pain.org/publications/iasp‐news/iasp‐position‐statement... Accessed November 1, 2021
-
- Wang, L. , Hong, P. J. , May, C. , Rehman, Y. , Oparin, Y. , Hong, C. J. , Hong, B. Y. , AminiLari, M. , Gallo, L. , Kaushal, A. , Craigie, S. , Couban, R. J. , Kum, E. , Shanthanna, H. , Price, I. , Upadhye, S. , Ware, M. A. , Campbell, F. , Buchbinder, R. , … Busse, J. W. (2021). Medical cannabis or cannabinoids for chronic non‐cancer and cancer related pain: a Systematic review and meta‐analysis of randomised clinical trials. BMJ, 374, n1034. 10.1136/bmj.n1034. PMID: 34497047. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
